| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Crystal structure of glycoprotein B from herpes simplex virus 1.
|
Science
|
2006
|
5.57
|
|
2
|
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
|
Nature
|
2004
|
3.65
|
|
3
|
Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.
|
EMBO J
|
2005
|
2.95
|
|
4
|
Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL.
|
Nat Struct Mol Biol
|
2010
|
2.45
|
|
5
|
Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion.
|
Proc Natl Acad Sci U S A
|
2007
|
2.43
|
|
6
|
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
|
J Virol
|
2004
|
2.21
|
|
7
|
Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.
|
J Virol
|
2005
|
2.07
|
|
8
|
Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).
|
J Virol
|
2002
|
2.03
|
|
9
|
Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
|
J Virol
|
2005
|
1.94
|
|
10
|
Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.
|
J Virol
|
2003
|
1.92
|
|
11
|
Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.
|
J Virol
|
2010
|
1.91
|
|
12
|
The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry.
|
Proc Natl Acad Sci U S A
|
2004
|
1.89
|
|
13
|
Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
|
J Virol
|
2005
|
1.85
|
|
14
|
Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B.
|
J Virol
|
2007
|
1.79
|
|
15
|
Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.
|
J Virol
|
2003
|
1.78
|
|
16
|
Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
|
Virology
|
2004
|
1.73
|
|
17
|
Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusion.
|
J Virol
|
2010
|
1.70
|
|
18
|
Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops.
|
J Virol
|
2009
|
1.65
|
|
19
|
Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions.
|
J Virol
|
2007
|
1.56
|
|
20
|
Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D.
|
J Biol Chem
|
2002
|
1.53
|
|
21
|
Structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1.
|
PLoS Pathog
|
2011
|
1.53
|
|
22
|
Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.
|
Virology
|
2005
|
1.49
|
|
23
|
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
|
J Virol
|
2005
|
1.44
|
|
24
|
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
|
Proc Natl Acad Sci U S A
|
2006
|
1.44
|
|
25
|
A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
|
Vaccine
|
2006
|
1.43
|
|
26
|
Potential nectin-1 binding site on herpes simplex virus glycoprotein d.
|
J Virol
|
2005
|
1.39
|
|
27
|
In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.
|
J Virol
|
2004
|
1.39
|
|
28
|
Contribution of cysteine residues to the structure and function of herpes simplex virus gH/gL.
|
Virology
|
2005
|
1.27
|
|
29
|
Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection.
|
J Virol
|
2003
|
1.21
|
|
30
|
Effects of herpes simplex virus on structure and function of nectin-1/HveC.
|
J Virol
|
2002
|
1.20
|
|
31
|
Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by Nectin-1/HveC.
|
J Virol
|
2003
|
1.20
|
|
32
|
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
|
J Exp Med
|
2008
|
1.19
|
|
33
|
Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
|
Virology
|
2002
|
1.19
|
|
34
|
Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.
|
J Virol
|
2002
|
1.19
|
|
35
|
Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
|
J Virol
|
2007
|
1.19
|
|
36
|
Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusion.
|
J Virol
|
2003
|
1.18
|
|
37
|
Alpha-herpesvirus glycoprotein D interaction with sensory neurons triggers formation of varicosities that serve as virus exit sites.
|
J Cell Biol
|
2006
|
1.17
|
|
38
|
The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D.
|
Virology
|
2008
|
1.17
|
|
39
|
Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
|
J Virol
|
2006
|
1.16
|
|
40
|
N-terminal mutants of herpes simplex virus type 2 gH are transported without gL but require gL for function.
|
J Virol
|
2007
|
1.14
|
|
41
|
Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1.
|
J Virol
|
2010
|
1.14
|
|
42
|
Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimeras.
|
J Virol
|
2003
|
1.13
|
|
43
|
Crystallization and preliminary diffraction studies of the ectodomain of the envelope glycoprotein D from herpes simplex virus 1 alone and in complex with the ectodomain of the human receptor HveA.
|
Acta Crystallogr D Biol Crystallogr
|
2002
|
1.11
|
|
44
|
Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes.
|
J Virol
|
2006
|
1.09
|
|
45
|
Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry.
|
J Virol
|
2007
|
1.09
|
|
46
|
Vaccinia virus exhibits cell-type-dependent entry characteristics.
|
Virology
|
2009
|
1.09
|
|
47
|
Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts.
|
J Neurovirol
|
2005
|
1.08
|
|
48
|
Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors.
|
MBio
|
2013
|
1.07
|
|
49
|
Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.
|
Nat Med
|
2008
|
1.07
|
|
50
|
Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.
|
J Virol
|
2010
|
1.07
|
|
51
|
Capturing the herpes simplex virus core fusion complex (gB-gH/gL) in an acidic environment.
|
J Virol
|
2011
|
1.07
|
|
52
|
Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.
|
J Virol
|
2008
|
1.01
|
|
53
|
Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus.
|
J Immunol
|
2007
|
1.00
|
|
54
|
The structure of herpesvirus fusion glycoprotein B-bilayer complex reveals the protein-membrane and lateral protein-protein interaction.
|
Structure
|
2013
|
1.00
|
|
55
|
Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.
|
J Virol
|
2006
|
1.00
|
|
56
|
Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection.
|
J Virol
|
2003
|
1.00
|
|
57
|
Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization.
|
J Virol
|
2011
|
0.99
|
|
58
|
Antibody responses to vaccinia membrane proteins after smallpox vaccination.
|
J Infect Dis
|
2007
|
0.99
|
|
59
|
Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans.
|
Virology
|
2009
|
0.99
|
|
60
|
A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.
|
Vaccine
|
2010
|
0.98
|
|
61
|
Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity of herpes simplex virus gB.
|
J Virol
|
2009
|
0.93
|
|
62
|
Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4.
|
J Virol
|
2002
|
0.93
|
|
63
|
Entry of herpesviruses into cells: the enigma variations.
|
Adv Exp Med Biol
|
2013
|
0.92
|
|
64
|
Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins.
|
J Virol
|
2013
|
0.92
|
|
65
|
Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
|
J Virol
|
2013
|
0.92
|
|
66
|
Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.
|
PLoS One
|
2011
|
0.92
|
|
67
|
Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.
|
Vaccine
|
2011
|
0.90
|
|
68
|
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
|
Vaccine
|
2008
|
0.87
|
|
69
|
Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.
|
J Virol
|
2007
|
0.86
|
|
70
|
Induction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1.
|
Virology
|
2013
|
0.81
|
|
71
|
The membrane-proximal region (MPR) of herpes simplex virus gB regulates association of the fusion loops with lipid membranes.
|
MBio
|
2012
|
0.81
|
|
72
|
Displacement of the C terminus of herpes simplex virus gD is sufficient to expose the fusion-activating interfaces on gD.
|
J Virol
|
2013
|
0.80
|
|
73
|
Role of sulfatide in vaccinia virus infection.
|
Biol Cell
|
2011
|
0.80
|
|
74
|
Spatiotemporal changes of the herpes simplex virus entry receptor nectin-1 in murine brain during postnatal development.
|
J Neurovirol
|
2006
|
0.78
|
|
75
|
The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entry.
|
J Virol
|
2012
|
0.77
|
|
76
|
The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.
|
J Virol
|
2013
|
0.75
|